I agree that this site is using cookies. You can find further informations here.
X
Dashtipour, Khashayar
106  results:
Search for persons X
?
1

Persistence, Health Care Resource Utilization, and Costs Am..:

Dashtipour, Khashayar ; Sadeghi, Marjan ; Heath, Maria...
Toxicon.  237 (2024)  - p. 107386 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Safety and Real-World Dosing of OnabotulinumtoxinA for the ..:

Bavikatte, Ganesh ; Esquenazi, Alberto ; Dimyan, Michael A....
American Journal of Physical Medicine & Rehabilitation.  103 (2024)  7 - p. 580-587 , 2024
Link: https://doi.org/10.1097/..
 
?
3

Efficacy and Safety of DaxibotulinumtoxinA for Injection in..:

Comella, Cynthia L. ; Jankovic, Joseph ; Hauser, Robert A....
Neurology.  102 (2024)  4 - p. , 2024
Link: https://doi.org/10.1212/..
 
?
4

Comparative Analysis of Deutetrabenazine and Valbenazine as..:

Golsorkhi, Mohadese ; Koch, Jessa ; Pedouim, Farzin...
Tremor and Other Hyperkinetic Movements.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.5334/..
 
?
5

Real-world differences in dosing and clinical utilization o..:

Bohart, Zachary ; Dashtipour, Khashayar ; Kim, Heakyung...
Toxicon.  241 (2024)  - p. 107678 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Safety of Foslevodopa/Foscarbidopa During Optimization and ..:

Kern, Drew ; Dashtipour, Khashayar ; Aldred, Jason...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
7

Mental health disparities and the role of perceived discrim..:

Jones, Jacob D. ; Uribe-Kirby, Ruth ; Rivas, Rhiannon...
Parkinsonism & Related Disorders.  116 (2023)  - p. 105867 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Characteristics and Treatment Response to Onabotulinumtoxin..:

Dashtipour, Khashayar ; Jankovic, Joseph ; Charles, David...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
9

Continuous, Subcutaneous Apomorphine Infusion for Persisten..:

Isaacson, Stuart ; Ceresoli-Borroni, Gianpiera ; Espay, Alberto...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
10

High rates of blood transfusion associated with Parkinson's..:

Shahrestani, Shane ; Gendreau, Julian ; Tafreshi, Ali R...
Neurological Sciences.  43 (2022)  8 - p. 4761-4768 , 2022
Link: https://doi.org/10.1007/..
 
?
11

Characteristics and Treatment Response to Onabotulinumtoxin..:

Dashtipour, Khashayar ; Jankovic, Joseph ; Charles, David...
Toxicon.  214 (2022)  - p. S59 , 2022
Link: https://doi.org/10.1016/..
 
?
12

AbobotulinumtoxinA provides flexibility for the treatment o..:

Lew, Mark F. ; Hauser, Robert A. ; Isaacson, Stuart H....
Clinical Parkinsonism & Related Disorders.  5 (2021)  - p. 100115 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Correction: Sustained functional benefits after a single se..:

Patel, Atul T. ; Lew, Mark F. ; Dashtipour, Khashayar...
PLOS ONE.  16 (2021)  4 - p. e0250475 , 2021
Link: https://doi.org/10.1371/..
 
?
14

Management Strategies for Comorbid Supine Hypertension in P..:

Isaacson, Stuart H. ; Dashtipour, Khashayar ; Mehdirad, Ali A..
Current Neurology and Neuroscience Reports.  21 (2021)  4 - p. , 2021
Link: https://doi.org/10.1007/..
 
?
15

Pimavanserin Treatment for Parkinson's Disease Psychosis in..:

Dashtipour, Khashayar ; Gupta, Fiona ; Hauser, Robert A....
Parkinson's Disease.  2021 (2021)  - p. 1-10 , 2021
Link: https://doi.org/10.1155/..
 
1-15